Advertisement
ST Pharm Co.,Ltd. (237690.KQ)
KOSDAQ - KOSDAQ Delayed Price. Currency in KRW
Follow
At close: 03:30PM KST
| Previous Close | 100,900.00 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 0.00 - 0.00 |
| 52 Week Range | |
| Volume | |
| Avg. Volume | 500,381 |
| Market Cap | 1.9T |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Jan 30, 2025 - Feb 03, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 118,667.00 |
PR NewswireST Pharm Presented '100-Day Expedite Strategy', Preparedness and Proactive Measures for Future Pandemic at Korea-CEPI R&D Workshop
Nov. 21, 2023 local time, ST Pharm announced 'Rapid Preparedness of Pandemic Vaccine in 100 Days using ST Pharm's own mRNA Platform Technology' at the Korea-CEPI R&D Workshop in World Bio Summit 2023, organized by Korea Health Industry Development Institute (KHIDI) and Coalition for Epidemic Preparedness Innovations (CEPI). During the main speaker session, Joo-Sung James Yang, Ph.D., SVP Head of Biotechnology R&D at ST Pharm, addressed the strategy, which aims to develop pandemic vaccines agains
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.